STOCK TITAN

Novus Stock Price, News & Analysis

NDEV OTC

Welcome to our dedicated page for Novus news (Ticker: NDEV), a resource for investors and traders seeking the latest updates and insights on Novus stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Novus's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Novus's position in the market.

Rhea-AI Summary

Novus Acquisition and Development Corp. (OTC PINK:NDEV) reported its financial results for the year ending December 31, 2020. Revenue rose by 11% to $242,382, with a 34% profit margin in Q4. Operating income increased by 37% to $21,047 in the fourth quarter. Shareholder equity grew to $1,468,783, and cash reserves improved to $156,422. The company secured contracts with various health carriers, integrating its cannabis health plans into their offerings. No dilution occurred in Q4 2020, highlighting stability amid market challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.23%
Tags
none
-
News
Rhea-AI Summary

Novus Acquisition and Development, Corp. (NDEV) reported its operational and financial results for Q3 2020, highlighting a significant integration of cannabis health plans with guaranteed issued carrier plans. Revenue rose 9% to $61,299 year-over-year, with net income increasing 35% to $20,686. Key partnerships were established with Medova Healthcare and Unique Insurance Concepts, expanding their service offerings. Notably, Novus maintains a strong balance sheet with increased shareholder equity and cash reserves, while also implementing a COVID-19 strategy to retain members during employment disruptions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12%
Tags

FAQ

What is the current stock price of Novus (NDEV)?

The current stock price of Novus (NDEV) is $0.0178 as of May 6, 2026.

What is the market cap of Novus (NDEV)?

The market cap of Novus (NDEV) is approximately 3.8M.